Watchlist Price Alert

Prometheus Biosciences In... (RXDX)

NASDAQ: RXDX · Real-Time Price · USD

199.92

0.18 (0.09%)

At close: Jun 15, 2023, 8:00 PM

Prometheus Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2016	Dec 31, 2015
Net Income	-141.75M	-90.19M	-31.14M	-16.73M	-103.64M	-92.46M
Depreciation & Amortization	629K	258K	109K	35K	3.48M	2.04M
Stock-Based Compensation	20.86M	10.7M	739K	206K	7.72M	5.34M
Other Working Capital	-3.46M	16.05M	6.67M	-925K	-17.21M	44.79M
Other Non-Cash Items	865K	2.26M	1.69M	916K	19.45M	-13.37M
Deferred Income Tax	-2.68M	659K	1.91M	-4.29M	n/a	n/a
Change in Working Capital	-1.18M	12.82M	-1.33M	-334K	-17.12M	47.65M
Operating Cash Flow	-123.25M	-63.51M	-28.02M	-20.2M	-90.11M	-50.8M
Capital Expenditures	-2.7M	-1.14M	-204K	-279K	-2.45M	-3.52M
Cash Acquisitions	403.78M	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-478.68M	n/a	n/a	n/a	-123.86M	-148.11M
Sales Maturities Of Investments	77.6M	n/a	n/a	n/a	140.5M	90.66M
Other Investing Acitivies	-403.78M	n/a	-859K	8.21M	75K	n/a
Investing Cash Flow	-403.78M	-1.14M	-1.06M	7.93M	14.27M	-60.97M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	428K	n/a	n/a	n/a	n/a
Dividend Paid	n/a	-428K	n/a	n/a	n/a	n/a
Other Financial Acitivies	562.2M	268.12M	79.89M	9.76M	36.27M	141.42M
Financial Cash Flow	562.2M	267.69M	79.89M	9.76M	36.27M	141.42M
Net Cash Flow	35.17M	203.05M	50.8M	-2.51M	-22.04M	40.04M
Free Cash Flow	-125.96M	-64.64M	-28.22M	-20.48M	-92.56M	-54.32M